Later, using a mouse model of AD (3xTgAD), Segura-Uribe et al. (2022) confirmed the previous findings by showing that tibolone at 1 mg/kg reduced Aβ and tau in the hippocampus of transgenic animals, which was associated with a significant improvement in memory processes [108]. Here, MAPT is linked to Alzheimer disease.